BFM 89.9

HIGHLIGHTS 
Podcast  >  Bigger Picture  >  Health & Living  >  Can We Afford The First Pill for COVID-19?

Can We Afford The First Pill for COVID-19?

Sangeeta Shashikant, Programme Director on Development & Intellectual Property, Third World Network

02-Nov-21 16:35

Can We Afford The First Pill for COVID-19?

Merck & Co’s oral antiviral for COVID-19 is being called a “game-changer”, as it would be the first pill available to treat early infection. In another first, the company has agreed to a licensing deal that will allow the drug to be made and sold cheaply in 105 low-income countries. We ask Sangeeta Shashikant, Programme Director on Development & Intellectual Property, Third World Network, whether this move will be enough to make the drug accessible, especially when rich countries look set to hoard supplies amid already existing vaccine inequity.

Listen to Part 1 here, where we explore how molnupiravir works and how it could change the way COVID-19 is managed.

Image credit: The Intercept

Produced by: Lim Sue Ann and Tee Shiao Eek


This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  Personal FinanceInvestmentsFinancial LiteracyYoung FinancePersonal DevelopmentEntrpreneurshipPoliticsSocial IssuesBusiness AnalysisAutolaw & legal mattersHealth PolicyDiseases & ConditionsMental HealthHealthy LivingFitnessMedical Innovation and TechnologySMEMarketsScience

Tags:  The Bigger PictureHealth & LivingCOVID-19Merckmolnupiravirantiviralremdesivirequitygenericintellectual propertymedicines patent poolIP waiver





Play / Pause

Listen now : The Breakfast Grille Repeat:

Today’s Shows



6:00 AM

The 6AM Stretch

7:00 AM

World Market Watch

Vishnu Varathan, Head of Economics & Strategy, Mizuho Bank

7:15 AM

Morning Brief

7:30 AM

Morning Brief

Dr. Benjamin Barton, Associate Professor, University of Nottingham Malaysia

7:45 AM

Top Story

Dan Ives, Managing Director, Wedbush Securities

8:00 AM

The Breakfast Grille

Datuk Dr. Ahmad Parveez Ghulam Kadir, Director General of the Malaysian Palm Oil Board (MPOB) (SHAZ)

8:30 AM

Morning Brief

Thomas Daniel, Senior Fellow, ISIS Malaysia

8:45 AM

Morning Brief

9:00 AM

Opening Bell

9:15 AM

Opening Bell

Adam Mohamed Rahim, Equity Research Analyst, RHB Research

9:35 AM

Ringgit & Sense

Dr Amirul, Research Associate, Khazanah Research Institute (KRI)

10:05 AM

Open For Business

Robin Chase, Co-Founder of Zipcar and Global Transportation Entrepreneur

11:00 AM

Tech Talk

Dr Ian Tan, Associate Professor and Head of School of Mathematical and Computer Sciences, Heriot-Watt University (REPEAT)

12:00 PM

Enterprise Explores

Warren Leow, CEO, Pixlr Group (REPEAT)

1:00 PM

The Breakfast Grille Repeat

2:05 PM

Discovery Hour

History on Repeat #8: The Making of Malaysian Identities, Sumit K. Mandal, Associate Professor, Faculty of Social Sciences, University of Nottingham Malaysia Campus

3:05 PM

Beyond the Ballot Box

4:05 PM

Health & Living

Public Health: How (Un)Healthy Are Malaysians, According to NHMS 2023? Azrul Mohd Khalib, CEO, Galen Centre for Health & Social Policy | Professor Dr Sharifa Ezat Wan Puteh, Professor in Health Economics, Hospital & Health Management, Faculty of Medicine, Universiti Kebangsaan Malaysia

5:00 PM

Top 5 at 5

6:00 PM

Inside Story

Talkback Thursday

7:30 PM

Beyond the Ballot Box (REPEAT)

9:00 PM

I Love KL

10:00 PM

Back To Back